WO2011049851A2 - Antiperspirant products and processes for fabricating the same - Google Patents

Antiperspirant products and processes for fabricating the same Download PDF

Info

Publication number
WO2011049851A2
WO2011049851A2 PCT/US2010/053007 US2010053007W WO2011049851A2 WO 2011049851 A2 WO2011049851 A2 WO 2011049851A2 US 2010053007 W US2010053007 W US 2010053007W WO 2011049851 A2 WO2011049851 A2 WO 2011049851A2
Authority
WO
WIPO (PCT)
Prior art keywords
antiperspirant
vol
antiperspirant product
carrier
isoparaffin
Prior art date
Application number
PCT/US2010/053007
Other languages
French (fr)
Other versions
WO2011049851A3 (en
Inventor
Thomas Doering
Cheryl Galante
Original Assignee
The Dial Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Dial Corporation filed Critical The Dial Corporation
Priority to EP10825458A priority Critical patent/EP2490664A2/en
Publication of WO2011049851A2 publication Critical patent/WO2011049851A2/en
Publication of WO2011049851A3 publication Critical patent/WO2011049851A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone

Definitions

  • the present invention generally relates to antiperspirant products and processes for making them, and more particularly relates to antiperspirant products that exhibit reduced white residue and processes for making them.
  • Antiperspirants are popular personal care products used to prevent or eliminate sweat and body odor caused by sweat. Antiperspirant sticks are desired by a large majority of the population because of the presence of active antiperspirant compounds that minimize or prevent the secretion of sweat by blocking or plugging ducts of sweat- secreting glands, such as those located at the underarms. Antiperspirants typically comprise the active antiperspirant compound in a carrier that permits the antiperspirant product to be applied to the skin by swiping or rubbing the stick across the skin, typically of the underarm. Upon application, the carrier evaporates, releasing the active antiperspirant compound from the antiperspirant product to form plugs in the sweat ducts.
  • cyclomethicone such as cyclopentasiloxane or cyclotetrasiloxane
  • volatility rate substantially constant volatility or evaporation rate
  • an antiperspirant product comprises an active antiperspirant compound and a carrier having a first volatility rate in an air ambient at about 50°C and 1 atm after a first time period and a second volatility rate in an air ambient at about 50°C and 1 atm after a second time period, wherein the second volatility rate is less than the first volatility rate and the first time period is less than the second time period.
  • an antiperspirant product comprises an active antiperspirant compound and a carrier comprising a material selected from the group consisting of poly dimethyl siloxane, isoparaffin/alkane compounds, and combinations thereof.
  • a process for making an antiperspirant product comprises providing a carrier having a first volatility rate after about 10 minutes in an air ambient at about 50°C and 1 atm and a second volatility rate after about 100 minutes in an air ambient at about 50°C and 1 atm, wherein the second volatility rate is less than the first volatility rate.
  • the carrier and an active antiperspirant compound are combined at a first temperature to form a mixture and the mixture is cooled to a lower second temperature.
  • FIG. 1 is a graph of the volatility (percent weight lost) of cyclopentasiloxane over time at 50°C and at 1 atmosphere (atm);
  • FIG. 2 is a graph of the volatility (percent weight lost) of polydimethyl siloxane and SiClone Sr-5 over time at 50°C and at 1 atm compared to that of cyclopentasiloxane.
  • the various embodiments contemplated herein relate to antiperspirant products that exhibit reduced white residue deposition over time compared to conventional antiperspirant products, in particular conventional antiperspirant products comprising only a cyclomethicone as a carrier.
  • the various embodiments of the antiperspirant products contemplated herein comprise an active antiperspirant compound and a carrier having a first volatility rate after a first time period and a second volatility rate after a second, longer time period, wherein the second volatility rate is less than the first volatility rate.
  • the carrier evaporates quickly, leaving behind the active antiperspirant compound to plug sweat ducts of sweat-producing glands in the skin. After the antiperspirant product has been on the skin for an amount of time, the carrier evaporates less quickly, thus remaining on the skin to help mask white residue.
  • the antiperspirant product comprises a carrier having a first volatility rate in an air ambient at about 50°C and 1 atm. after a first time period and a second volatility rate in an air ambient at about 50°C and 1 atm. after a second time period, wherein the second volatility rate is less than the first volatility rate and the first time period is less than the second time period.
  • the carrier has a volatility rate in the range of about more than 7% weight loss after about 10 minutes in an air ambient at about 50°C and 1 atm and a volatility rate in the range of about less than 75% weight loss after about 100 minutes in an air ambient at about 50°C and 1 atm.
  • the carrier has a volatility rate in the range of about 10 to about 30 % weight loss after about 10 minutes in an air ambient at about 50°C and 1 atm and a volatility rate in the range of about 20 to about 70 % weight loss after about 100 minutes in an air ambient at about 50°C and 1 atm.
  • volatility rate refers to the percentage of weight of the carrier lost due to evaporation over a given time period.
  • the volatility rates of the carrier can be measured using the following testing procedure. Twenty (20) micron liters of carrier is loaded into a differential scanning calorimetry (DSC) cell of about 6 millimeters (mm) in diameter and about 1 mm in depth.
  • DSC differential scanning calorimetry
  • the DSC cell sits on a thermogravimetric analysis pan at 1 atm.
  • the temperature of the carrier is ramped up to about 50°C at a speed of about 10°C/minute and the temperature then is maintained at about 50°C for 100 minutes. Once the temperature reaches 50°C, the weight of the carrier is measured every 30 seconds.
  • the volatility rates are calculated by measuring the amount of weight lost by the carrier at 10 minutes after reaching 50°C and at 100 minutes after reaching 50°C and dividing each value of the weight lost by the total initial weight of the carrier and multiplying by 100.
  • Examples of carriers suitable for use in the various embodiments of the antiperspirant products contemplated herein include those comprising polydimethyl siloxane, such as for example, Oil M 3, available from Momentive Performance Materials of Albany, New York, an isoparaffin/alkane compound, such as SiClone SR-5 (C13-C16 isoparaffin/C12-C14 isoparaffin/C13-C15 alkane) available from Presperse LLC of Somerset, New Jersey, or the like, or combinations thereof.
  • FIG. 2 is a graph of the volatility rates of Oil M 3 and SiClone SR-5 compared to the volatility rate of cyclopentasiloxane.
  • both Oil M 3 and SiClone SR-5 exhibit a higher volatility rate within the first 10 minutes of exposure to air ambient at 50°C and 1 atm and a lower volatility rate after about 100 minutes of exposure to air ambient at 50°C and 1 atm.
  • the carrier may comprise about 100% of polydimethyl siloxane or about 100% isoparaffin/alkane compound or may comprise one or both of these materials along with other carrier agents.
  • the carrier may comprise a 20/80 vol. %, 40/60 vol. %, 50/50 vol. %, 60/40 vol. %, or 80/20 vol.
  • the carrier may comprise a 20/80 volume percent (vol. %), 40/60 vol. %, or 50/50 vol. % mixture of a cyclomethicone, such as cyclopentasiloxane, cyclotetrasiloxane, or the like, and polydimethyl siloxane, respectively.
  • the carrier may comprise a 20/80 vol. % or 40/60 vol. % mixture of a cyclomethicone and an isoparaffin/alkane compound, respectively.
  • the carrier may comprise a 20/50/30 vol.
  • the carrier comprises polydimethyl siloxane.
  • the carrier comprises about 30 to about 60 wt. % of the antiperspirant product.
  • the antiperspirant product comprises about 40 wt. % polydimethyl siloxane.
  • the various embodiments of the antiperspirant products also comprise a water- soluble active antiperspirant compound.
  • Active antiperspirant compounds contain at least one active ingredient, typically metal salts, that are thought to reduce sweating by diffusing through the sweat ducts of apocrine glands (sweat glands responsible for body odor) and hydrolyzing in the sweat ducts, where they combine with proteins to form an amorphous metal hydroxide agglomerate, plugging the sweat ducts so sweat cannot diffuse to the skin surface.
  • Some active antiperspirant compounds that may be used in the antiperspirant product include astringent metallic salts, especially inorganic and organic salts of aluminum, zirconium, and zinc, as well as mixtures thereof.
  • aluminum-containing and/or zirconium-containing salts or materials such as aluminum halides, aluminum chlorohydrates, aluminum hydroxyhalides, zirconyl oxyhalides, zirconyl hydroxyhalides, and mixtures thereof.
  • Exemplary aluminum salts include those having the general formula Al 2 (OH) a Clb x (3 ⁇ 40), wherein a is from 2 to about 5; a and b total to about 6; x is from 1 to about 6; and wherein a, b, and x may have non- integer values.
  • Exemplary zirconium salts include those having the general formula ZrO(OH) 2-a Cl a x (H 2 0), wherein a is from about 1.5 to about 1.87, x is from about 1 to about7, and wherein a and x may both have non-integer values.
  • Particularly preferred zirconium salts are those complexes that additionally contain aluminum and glycine, commonly known as ZAG complexes. These ZAG complexes contain aluminum chlorohydroxide and zironyl hyroxy chloride conforming to the above-described formulas.
  • active antiperspirant compounds suitable for use in the various embodiments contemplated herein include aluminum dichlorohydrate, aluminum- zirconium octachlorohydrate, aluminum sesquichlorohydrate, aluminum chlorohydrex propylene glycol complex, aluminum dichlorohydrex propylene glycol complex, aluminum sesquichlorohydrex propylene glycol complex, aluminum chlorohydrex polyethylene glycol complex, aluminum dichlorohydrex polyethylene glycol complex, aluminum sesquichlorohydrex polyethylene glycol complex, aluminum-zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrate, aluminum zirconium trichlorohydrex glycine complex, aluminum zirconium tetrachlorohydrex glycine complex, aluminum zirconium pentachlorohydrex glycine complex, aluminum zirconium octachlorohydrex glycine complex
  • the active antiperspirant compound is aluminum zirconium pentachlorohydrex glycine.
  • the antiperspirant product comprises an active antiperspirant compound at an active level of about 8 to about 30 wt. % of the total antiperspirant product. In a most preferred embodiment, the antiperspirant product comprises about 21-22 wt. % aluminum zirconium pentachlorohydrex glycine.
  • At least one structurant and/or gellant that facilitates the solid consistency of the antiperspirant stick product.
  • structurants Naturally-occurring or synthetic waxy materials or combinations thereof can be used as such structurants.
  • Suitable structurants, including waxes and gellants are often selected from fatty alcohols often containing from 12 to 30 carbons, such as stearyl alcohol, behenyl alcohol and sterols such as lanosterol.
  • fatty means a long chain aliphatic group, such as at least 8 or 12 linear carbons, which is frequently not branched (linear) and is typically saturated, but which can alternatively be branched and/or unsaturated. It is possible for the fatty acid to contain a hydroxyl group, as in 12-hydroxystearic acid, for example as part of a gellant combination, and to employ amido or ester derivates thereof.
  • Other structurants can comprise hydrocarbon waxes such as paraffin waxes, microcrystalline waxes, ceresin, squalene, and polyethylene waxes.
  • Other suitable structurants are waxes derived or obtained from plants or animals such as hydrogenated castor oil, hydrogenated soybean oil, carnabau, spermacetti, candelilla, beeswax, modified beeswaxes, and Montan wax and individual waxy components thereof. It is especially suitable herein to employ a mixture of wax structurants. Suitable mixtures of structurants can reduce the visibility of active antiperspirant compounds deposited on the skin and result in either a soft solid or a firm solid.
  • the surfactant(s) comprise about 10 to about 35 wt. % of the total antiperspirant product.
  • the antiperspirant product comprises a mixture of stearyl alcohol and hydrogenated castor oil.
  • the antiperspirant product comprises about 12 to about 25 wt. % stearyl alcohol and about 1.5 to about 7 wt. % hydrogenated castor oil.
  • the antiperspirant product comprises about 20 - 22 wt. % stearyl alcohol and 2.8 wt. % hydrogenated castor oil.
  • the antiperspirant products also may comprise a high refractive index (R.I.) hydrophobic compound.
  • R.I. refractive index
  • the term "high refractive index” means a refractive index of no less than about 1.4.
  • the high R.I. hydrophobic compound also facilitates the minimization and/or prevention of a white residue on the skin by masking the active antiperspirant salt that stays upon the skin upon evaporation of the carrier.
  • Examples of high R.I. hydrophobic compounds for use in the antiperspirant products include PPG-14 butyl ether, C12-C15 alkyl benzoate, such as Finsolv TN® available from Innospec of the United Kingdom, and phenyl dimethicone.
  • the antiperspirant product comprises PPG-14 butyl ether and, in a more preferred embodiment, the antiperspirant product comprises PPG-14 butyl ether in an amount of about 5 to about 15 wt. % of the total antiperspirant product. In a most preferred embodiment, the antiperspirant product comprises about 9.8 wt. % PPG-14 butyl ether.
  • the antiperspirant product comprises one or more suspending agents that facilitate suspension of the active antiperspirant compound in the antiperspirant product, thereby minimizing the amount of active antiperspirant compound that settles out of the antiperspirant product during manufacture. Suitable suspending agents include clays and silicas.
  • Suitable silicas include fumed silicas and silica derivatives, such as silica dimethyl silylate.
  • Suitable clays include bentonites, hectorites and colloidal magnesium aluminum silicates.
  • the antiperspirant product comprises about 0.5 to about 2.5 wt. % suspending agents.
  • the antiperspirant product comprises a mixture of silica and silica dimethyl silylate.
  • the antiperspirant product comprises about 0.3 wt. % silica and about 1.4 wt. % silica dimethyl silylate.
  • the antiperspirant product may comprise additives, such as those used in conventional antiperspirants.
  • additives include, but are not limited to, fragrances, including encapsulated fragrances, dyes, pigments, preservatives, antioxidants, moisturizers, and the like.
  • fragrances including encapsulated fragrances, dyes, pigments, preservatives, antioxidants, moisturizers, and the like.
  • optional ingredients can be included in the antiperspirant product in an amount of 0 to about 20 wt. %.
  • the antiperspirant product comprises about 1.9 % myristyl myristate, which provides a conditioning effect to the skin.
  • the antiperspirant products can be prepared by first combining the structurants and then melting them or, alternatively, melting each structurant and then mixing them. The remaining ingredients can be added to the melted structurants, either separately or as one or more premixtures, to form a liquid antiperspirant product, which is then poured into molds and permitted to cool at room temperature to form a solid stick antiperspirant product.
  • the antiperspirant product of the Example was prepared by combining the hydrogenated castor oil, stearyl alcohol, PPG- 14 butyl ether, and myristyl myristate, melting the combination at 85°C, and then permitting the combination to cool to about 60-65°C.
  • a premixture of aluminum zirconium pentachlorohydrex glycine, polydimethyl siloxane, silica, and silica dimethyl silylate was formed and then added to the cooled combination. The liquid was poured into a stick mold having a temperature of 52°C and was permitted to cool to room temperature.
  • antiperspirant products that exhibit reduced white residue deposition over time compared to conventional antiperspirant products, in particular conventional antiperspirant products comprising cyclomethicone, and processes for making them have been provided.
  • the various embodiments of the antiperspirant products contemplated herein comprise an active antiperspirant compound and a carrier having a first volatility rate in an air ambient at about 50°C and 1 atm after a first time period and a second volatility rate in an air ambient at about 50°C and 1 atm after a second, longer time period, wherein the second volatility rate is less than the first volatility rate.
  • the carrier evaporates quickly, leaving behind the active antiperspirant compound to plug sweat ducts of sweat-producing glands in the skin. After the first time period, the carrier evaporates at a slower volatility rate, thus remaining on the skin to help mask white residue.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

Antiperspirant products and processes for making them are provided. In one embodiment, an antiperspirant product comprises an active antiperspirant compound and a carrier having a first volatility rate in an air ambient at about 50°C and 1 atm after a first time period and a second volatility rate in an air ambient at about 50°C and 1 atm after a second time period, wherein the second volatility rate is less than the first volatility rate and the first time period is less than the second time period.

Description

ANTIPERSPIRANT PRODUCTS AND PROCESSES FOR FABRICATING THE
SAME
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] The present application claims priority to U. S. Utility Application 12/581,516 filed October 19, 2009 and entitled "ANTIPERSPIRANT PRODUCTS AND PROCESSES FOR FABRICATING THE SAME", which is incorporated herein.
FIELD OF THE INVENTION
[0002] The present invention generally relates to antiperspirant products and processes for making them, and more particularly relates to antiperspirant products that exhibit reduced white residue and processes for making them.
BACKGROUND OF THE INVENTION
[0003] Antiperspirants are popular personal care products used to prevent or eliminate sweat and body odor caused by sweat. Antiperspirant sticks are desired by a large majority of the population because of the presence of active antiperspirant compounds that minimize or prevent the secretion of sweat by blocking or plugging ducts of sweat- secreting glands, such as those located at the underarms. Antiperspirants typically comprise the active antiperspirant compound in a carrier that permits the antiperspirant product to be applied to the skin by swiping or rubbing the stick across the skin, typically of the underarm. Upon application, the carrier evaporates, releasing the active antiperspirant compound from the antiperspirant product to form plugs in the sweat ducts.
[0004] However, antiperspirant users often are disappointed in the chalky, white residue that remains on the skin after the carrier evaporates. The white residue is formed from the active antiperspirant compound and waxes. Conventional antiperspirant sticks typically comprise a cyclomethicone, such as cyclopentasiloxane or cyclotetrasiloxane, as the carrier. As illustrated in FIG. 1, cyclomethicones such as cyclopentasiloxane have a substantially constant volatility or evaporation rate (herein referred to as volatility rate), similar to that of water. The longer the antiperspirant is on the skin, the more the carrier evaporates and the more white residue is left behind on the skin.
[0005] Accordingly, it is desirable to provide antiperspirant products that exhibit reduced white residue compared to conventional antiperspirant products. In addition, it is desirable to provide antiperspirant products that comprise a carrier having a varying volatility rate. It is also desirable to provide processes for making the antiperspirant products. Furthermore, other desirable features and characteristics of the present invention will become apparent from the subsequent detailed description of the invention and the appended claims, taken in conjunction with the accompanying drawings and this background of the invention.
BRIEF SUMMARY OF THE INVENTION
[0006] Antiperspirant products and processes for making them are provided. In accordance with an exemplary embodiment, an antiperspirant product comprises an active antiperspirant compound and a carrier having a first volatility rate in an air ambient at about 50°C and 1 atm after a first time period and a second volatility rate in an air ambient at about 50°C and 1 atm after a second time period, wherein the second volatility rate is less than the first volatility rate and the first time period is less than the second time period.
[0007] In accordance with another exemplary embodiment, an antiperspirant product comprises an active antiperspirant compound and a carrier comprising a material selected from the group consisting of poly dimethyl siloxane, isoparaffin/alkane compounds, and combinations thereof.
[0008] In accordance with a further exemplary embodiment, a process for making an antiperspirant product comprises providing a carrier having a first volatility rate after about 10 minutes in an air ambient at about 50°C and 1 atm and a second volatility rate after about 100 minutes in an air ambient at about 50°C and 1 atm, wherein the second volatility rate is less than the first volatility rate. The carrier and an active antiperspirant compound are combined at a first temperature to form a mixture and the mixture is cooled to a lower second temperature. BRIEF DESCRIPTION OF THE DRAWINGS
[0009] The present invention will hereinafter be described in conjunction with the following drawing figures, wherein like numerals denote like elements, and wherein:
[0010] FIG. 1 is a graph of the volatility (percent weight lost) of cyclopentasiloxane over time at 50°C and at 1 atmosphere (atm); and
[0011] FIG. 2 is a graph of the volatility (percent weight lost) of polydimethyl siloxane and SiClone Sr-5 over time at 50°C and at 1 atm compared to that of cyclopentasiloxane.
DETAILED DESCRIPTION OF THE INVENTION
[0012] The following detailed description of the invention is merely exemplary in nature and is not intended to limit the invention or the application and uses of the invention. Furthermore, there is no intention to be bound by any theory presented in the preceding background of the invention or the following detailed description of the invention.
[0013] The various embodiments contemplated herein relate to antiperspirant products that exhibit reduced white residue deposition over time compared to conventional antiperspirant products, in particular conventional antiperspirant products comprising only a cyclomethicone as a carrier. Specifically, the various embodiments of the antiperspirant products contemplated herein comprise an active antiperspirant compound and a carrier having a first volatility rate after a first time period and a second volatility rate after a second, longer time period, wherein the second volatility rate is less than the first volatility rate. In this regard, within the first few minutes of application of the antiperspirant product to the skin, the carrier evaporates quickly, leaving behind the active antiperspirant compound to plug sweat ducts of sweat-producing glands in the skin. After the antiperspirant product has been on the skin for an amount of time, the carrier evaporates less quickly, thus remaining on the skin to help mask white residue.
[0014] In this regard, in one exemplary embodiment of the present invention, the antiperspirant product comprises a carrier having a first volatility rate in an air ambient at about 50°C and 1 atm. after a first time period and a second volatility rate in an air ambient at about 50°C and 1 atm. after a second time period, wherein the second volatility rate is less than the first volatility rate and the first time period is less than the second time period. In a preferred embodiment, the carrier has a volatility rate in the range of about more than 7% weight loss after about 10 minutes in an air ambient at about 50°C and 1 atm and a volatility rate in the range of about less than 75% weight loss after about 100 minutes in an air ambient at about 50°C and 1 atm. In a more preferred embodiment, the carrier has a volatility rate in the range of about 10 to about 30 % weight loss after about 10 minutes in an air ambient at about 50°C and 1 atm and a volatility rate in the range of about 20 to about 70 % weight loss after about 100 minutes in an air ambient at about 50°C and 1 atm. As used herein, the term "volatility rate" refers to the percentage of weight of the carrier lost due to evaporation over a given time period. The volatility rates of the carrier can be measured using the following testing procedure. Twenty (20) micron liters of carrier is loaded into a differential scanning calorimetry (DSC) cell of about 6 millimeters (mm) in diameter and about 1 mm in depth. The DSC cell sits on a thermogravimetric analysis pan at 1 atm. The temperature of the carrier is ramped up to about 50°C at a speed of about 10°C/minute and the temperature then is maintained at about 50°C for 100 minutes. Once the temperature reaches 50°C, the weight of the carrier is measured every 30 seconds. The volatility rates are calculated by measuring the amount of weight lost by the carrier at 10 minutes after reaching 50°C and at 100 minutes after reaching 50°C and dividing each value of the weight lost by the total initial weight of the carrier and multiplying by 100.
[0015] Examples of carriers suitable for use in the various embodiments of the antiperspirant products contemplated herein include those comprising polydimethyl siloxane, such as for example, Oil M 3, available from Momentive Performance Materials of Albany, New York, an isoparaffin/alkane compound, such as SiClone SR-5 (C13-C16 isoparaffin/C12-C14 isoparaffin/C13-C15 alkane) available from Presperse LLC of Somerset, New Jersey, or the like, or combinations thereof. FIG. 2 is a graph of the volatility rates of Oil M 3 and SiClone SR-5 compared to the volatility rate of cyclopentasiloxane. As is evident from the graph, while cyclopentasiloxane has a constant volatility rate over time, both Oil M 3 and SiClone SR-5 exhibit a higher volatility rate within the first 10 minutes of exposure to air ambient at 50°C and 1 atm and a lower volatility rate after about 100 minutes of exposure to air ambient at 50°C and 1 atm. The carrier may comprise about 100% of polydimethyl siloxane or about 100% isoparaffin/alkane compound or may comprise one or both of these materials along with other carrier agents. For example, in one embodiment, the carrier may comprise a 20/80 vol. %, 40/60 vol. %, 50/50 vol. %, 60/40 vol. %, or 80/20 vol. % mixture of a polydimethyl siloxane and an isoparaffin/alkane compound. In another embodiment, the carrier may comprise a 20/80 volume percent (vol. %), 40/60 vol. %, or 50/50 vol. % mixture of a cyclomethicone, such as cyclopentasiloxane, cyclotetrasiloxane, or the like, and polydimethyl siloxane, respectively. In another embodiment, the carrier may comprise a 20/80 vol. % or 40/60 vol. % mixture of a cyclomethicone and an isoparaffin/alkane compound, respectively. In yet another embodiment, the carrier may comprise a 20/50/30 vol. % mixture of a cyclomethicone, polydimethyl siloxane, and isoparaffin/alkane. Of course, any other combination of these or other carrier agents that meet the above-identified specifications can be used in the various embodiments of the antiperspirant products contemplated herein. In a preferred embodiment, the carrier comprises polydimethyl siloxane. In another preferred embodiment, the carrier comprises about 30 to about 60 wt. % of the antiperspirant product. In a more preferred embodiment, the antiperspirant product comprises about 40 wt. % polydimethyl siloxane.
[0016] The various embodiments of the antiperspirant products also comprise a water- soluble active antiperspirant compound. Active antiperspirant compounds contain at least one active ingredient, typically metal salts, that are thought to reduce sweating by diffusing through the sweat ducts of apocrine glands (sweat glands responsible for body odor) and hydrolyzing in the sweat ducts, where they combine with proteins to form an amorphous metal hydroxide agglomerate, plugging the sweat ducts so sweat cannot diffuse to the skin surface. Some active antiperspirant compounds that may be used in the antiperspirant product include astringent metallic salts, especially inorganic and organic salts of aluminum, zirconium, and zinc, as well as mixtures thereof. Particularly preferred are aluminum-containing and/or zirconium-containing salts or materials, such as aluminum halides, aluminum chlorohydrates, aluminum hydroxyhalides, zirconyl oxyhalides, zirconyl hydroxyhalides, and mixtures thereof. Exemplary aluminum salts include those having the general formula Al2(OH)aClb x (¾0), wherein a is from 2 to about 5; a and b total to about 6; x is from 1 to about 6; and wherein a, b, and x may have non- integer values. Exemplary zirconium salts include those having the general formula ZrO(OH)2-aCla x (H20), wherein a is from about 1.5 to about 1.87, x is from about 1 to about7, and wherein a and x may both have non-integer values. Particularly preferred zirconium salts are those complexes that additionally contain aluminum and glycine, commonly known as ZAG complexes. These ZAG complexes contain aluminum chlorohydroxide and zironyl hyroxy chloride conforming to the above-described formulas. Examples of active antiperspirant compounds suitable for use in the various embodiments contemplated herein include aluminum dichlorohydrate, aluminum- zirconium octachlorohydrate, aluminum sesquichlorohydrate, aluminum chlorohydrex propylene glycol complex, aluminum dichlorohydrex propylene glycol complex, aluminum sesquichlorohydrex propylene glycol complex, aluminum chlorohydrex polyethylene glycol complex, aluminum dichlorohydrex polyethylene glycol complex, aluminum sesquichlorohydrex polyethylene glycol complex, aluminum-zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrate, aluminum zirconium trichlorohydrex glycine complex, aluminum zirconium tetrachlorohydrex glycine complex, aluminum zirconium pentachlorohydrex glycine complex, aluminum zirconium octachlorohydrex glycine complex, zirconium chlorohydrate, aluminum chloride, aluminum sulfate buffered, and the like, and mixtures thereof. In a preferred embodiment, the active antiperspirant compound is aluminum zirconium pentachlorohydrex glycine. In a more preferred embodiment, the antiperspirant product comprises an active antiperspirant compound at an active level of about 8 to about 30 wt. % of the total antiperspirant product. In a most preferred embodiment, the antiperspirant product comprises about 21-22 wt. % aluminum zirconium pentachlorohydrex glycine.
[0017] Further included in the antiperspirant product is at least one structurant and/or gellant (hereinafter referred collectively as "structurant") that facilitates the solid consistency of the antiperspirant stick product. Naturally-occurring or synthetic waxy materials or combinations thereof can be used as such structurants. Suitable structurants, including waxes and gellants, are often selected from fatty alcohols often containing from 12 to 30 carbons, such as stearyl alcohol, behenyl alcohol and sterols such as lanosterol. As used herein, the term "fatty" means a long chain aliphatic group, such as at least 8 or 12 linear carbons, which is frequently not branched (linear) and is typically saturated, but which can alternatively be branched and/or unsaturated. It is possible for the fatty acid to contain a hydroxyl group, as in 12-hydroxystearic acid, for example as part of a gellant combination, and to employ amido or ester derivates thereof.
[0018] Other structurants can comprise hydrocarbon waxes such as paraffin waxes, microcrystalline waxes, ceresin, squalene, and polyethylene waxes. Other suitable structurants are waxes derived or obtained from plants or animals such as hydrogenated castor oil, hydrogenated soybean oil, carnabau, spermacetti, candelilla, beeswax, modified beeswaxes, and Montan wax and individual waxy components thereof. It is especially suitable herein to employ a mixture of wax structurants. Suitable mixtures of structurants can reduce the visibility of active antiperspirant compounds deposited on the skin and result in either a soft solid or a firm solid. In an exemplary embodiment, the surfactant(s) comprise about 10 to about 35 wt. % of the total antiperspirant product. In a preferred embodiment, the antiperspirant product comprises a mixture of stearyl alcohol and hydrogenated castor oil. In a more preferred embodiment, the antiperspirant product comprises about 12 to about 25 wt. % stearyl alcohol and about 1.5 to about 7 wt. % hydrogenated castor oil. In a most preferred embodiment, the antiperspirant product comprises about 20 - 22 wt. % stearyl alcohol and 2.8 wt. % hydrogenated castor oil.
[0019] The antiperspirant products also may comprise a high refractive index (R.I.) hydrophobic compound. As used herein, the term "high refractive index" means a refractive index of no less than about 1.4. The high R.I. hydrophobic compound also facilitates the minimization and/or prevention of a white residue on the skin by masking the active antiperspirant salt that stays upon the skin upon evaporation of the carrier. Examples of high R.I. hydrophobic compounds for use in the antiperspirant products include PPG-14 butyl ether, C12-C15 alkyl benzoate, such as Finsolv TN® available from Innospec of the United Kingdom, and phenyl dimethicone. In a preferred embodiment, the antiperspirant product comprises PPG-14 butyl ether and, in a more preferred embodiment, the antiperspirant product comprises PPG-14 butyl ether in an amount of about 5 to about 15 wt. % of the total antiperspirant product. In a most preferred embodiment, the antiperspirant product comprises about 9.8 wt. % PPG-14 butyl ether. [0020] In another exemplary embodiment, the antiperspirant product comprises one or more suspending agents that facilitate suspension of the active antiperspirant compound in the antiperspirant product, thereby minimizing the amount of active antiperspirant compound that settles out of the antiperspirant product during manufacture. Suitable suspending agents include clays and silicas. Examples of suitable silicas include fumed silicas and silica derivatives, such as silica dimethyl silylate. Suitable clays include bentonites, hectorites and colloidal magnesium aluminum silicates. In one exemplary embodiment, the antiperspirant product comprises about 0.5 to about 2.5 wt. % suspending agents. In another exemplary embodiment, the antiperspirant product comprises a mixture of silica and silica dimethyl silylate. In a preferred embodiment, the antiperspirant product comprises about 0.3 wt. % silica and about 1.4 wt. % silica dimethyl silylate.
[0021] In addition to the ingredients identified above, the antiperspirant product may comprise additives, such as those used in conventional antiperspirants. These additives include, but are not limited to, fragrances, including encapsulated fragrances, dyes, pigments, preservatives, antioxidants, moisturizers, and the like. These optional ingredients can be included in the antiperspirant product in an amount of 0 to about 20 wt. %. In a preferred embodiment, the antiperspirant product comprises about 1.9 % myristyl myristate, which provides a conditioning effect to the skin.
[0022] The antiperspirant products, according to various embodiments, can be prepared by first combining the structurants and then melting them or, alternatively, melting each structurant and then mixing them. The remaining ingredients can be added to the melted structurants, either separately or as one or more premixtures, to form a liquid antiperspirant product, which is then poured into molds and permitted to cool at room temperature to form a solid stick antiperspirant product.
[0023] The following is an exemplary embodiment of an antiperspirant product contemplated herein, with each of the components set forth in weight percent of the antiperspirant product. The example is provided for illustration purposes only and is not meant to limit the various embodiments of the antiperspirant product in any way. [0024] EXAMPLE
Ingredient Wt. %
Polydimethyl siloxane 40.0
Aluminum zirconium
pentachloride GLY 21.8
Stearyl Alcohol 22.0
PPG- 14 butyl ether 9.8
Hydrogenated castor oil 2.8
Myristyl Myristate 1.9
Silica 0.3
Silica dimethyl silylate 1.4
Total 100.0
[0025] The antiperspirant product of the Example was prepared by combining the hydrogenated castor oil, stearyl alcohol, PPG- 14 butyl ether, and myristyl myristate, melting the combination at 85°C, and then permitting the combination to cool to about 60-65°C. A premixture of aluminum zirconium pentachlorohydrex glycine, polydimethyl siloxane, silica, and silica dimethyl silylate was formed and then added to the cooled combination. The liquid was poured into a stick mold having a temperature of 52°C and was permitted to cool to room temperature.
[0026] Accordingly, antiperspirant products that exhibit reduced white residue deposition over time compared to conventional antiperspirant products, in particular conventional antiperspirant products comprising cyclomethicone, and processes for making them have been provided. Specifically, the various embodiments of the antiperspirant products contemplated herein comprise an active antiperspirant compound and a carrier having a first volatility rate in an air ambient at about 50°C and 1 atm after a first time period and a second volatility rate in an air ambient at about 50°C and 1 atm after a second, longer time period, wherein the second volatility rate is less than the first volatility rate. In this regard, within the first time period after application of the antiperspirant product to the skin, the carrier evaporates quickly, leaving behind the active antiperspirant compound to plug sweat ducts of sweat-producing glands in the skin. After the first time period, the carrier evaporates at a slower volatility rate, thus remaining on the skin to help mask white residue. [0027] While at least one exemplary embodiment has been presented in the foregoing detailed description of the invention, it should be appreciated that a vast number of variations exist. It should also be appreciated that the exemplary embodiment or exemplary embodiments are only examples, and are not intended to limit the scope, applicability, or configuration of the invention in any way. Rather, the foregoing detailed description will provide those skilled in the art with a convenient road map for implementing an exemplary embodiment of the invention, it being understood that various changes may be made in the function and arrangement of elements described in an exemplary embodiment without departing from the scope of the invention as set forth in the appended claims and their legal equivalents.

Claims

CLAIMS What is claimed is:
1. An antiperspirant product comprising:
an active antiperspirant compound; and
a carrier having a first volatility rate in ambient air at about 50°C and 1 atm. after a first time period and a second volatility rate in ambient air at about 50°C and 1 atm. after a second time period, wherein the second volatility rate is less than the first volatility rate and the first time period is less than the second time period.
2. The antiperspirant product of claim 1, wherein the first volatility rate is in the range of about more than 7% weight loss after about 10 minutes and the second volatility rate is in the range of about less than 75% weight loss after about 100 minutes.
3. The antiperspirant product of claim 2, wherein the first volatility rate is in the range of about 10 to about 30 % weight loss after about 10 minutes and the second volatility rate is in the range of about 20 to about 70 % weight loss after about 100 minutes.
4. The antiperspirant product of claim 1, wherein the carrier comprises a material selected from the group consisting of poly dimethyl siloxane, isoparaffin/alkane compounds, and mixtures thereof.
5. The antiperspirant product of claim 4, wherein the carrier comprises a mixture selected from the group consisting of 20/80 vol. %>, 40/60 vol. %>, and 50/50 vol. % cyclomethicone and polydimethyl siloxane, respectively.
6. The antiperspirant product of claim 5, wherein the cyclomethicone comprises cyclopentasiloxane or cyclotetrasiloxane.
7. The antiperspirant product of claim 4, wherein the carrier comprises a mixture selected from the group consisting of 20/80 vol. % and 40/60 vol. %
cyclomethicone and isoparaffin/alkane, respectively.
8. The antiperspirant product of claim 7, wherein the cyclomethicone comprises cyclopentasiloxane or cyclotetrasiloxane.
9. The antiperspirant product of claim 4, wherein the carrier comprises a mixture selected from the group consisting of 20/80 vol. %, 40/60 vol. %, 50/50 vol. %, 60/40 vol. %, and 80/20 vol. % polydimethyl siloxane and an isoparaffin/alkane compound.
10. The antiperspirant product of claim 4, wherein an isoparaffin/alkane compound comprises C13-C16 isoparaffin C12-C14 isoparaffin C13-C15 alkane.
11. The antiperspirant product of claim 1 , wherein the carrier is present in the antiperspirant product in an amount of about 30 to about 60 wt. %.
12. The antiperspirant product of claim 1, wherein the active antiperspirant compound is present in the antiperspirant product in an amount of about 8 to about 30 wt. %.
13. An antiperspirant product comprising:
an active antiperspirant compound; and
a carrier comprising a material selected from the group consisting of
polydimethyl siloxane, isoparaffin/alkane compounds, and combinations thereof.
14. The antiperspirant product of claim 13, wherein the carrier comprises a mixture selected from the group consisting of 20/80 vol. %, 40/60 vol. %, and 50/50 vol. %, cyclomethicone and polydimethyl siloxane, respectively.
15. The antiperspirant product of claim 14, wherein the cyclomethicone comprises cyclopentasiloxane or cyclotetrasiloxane.
16. The antiperspirant product of claim 13, wherein the carrier comprises a mixture selected from the group consisting of 20/80 vol. %, 40/60 vol. %, 50/50 vol. %, 60/40 vol. %, and 80/20 vol. % polydimethyl siloxane and a isoparaffin/alkane compound, respectively.
17. The antiperspirant product of claim 13, wherein the carrier comprises a mixture selected from the group consisting of 20/80 vol. % and 40/60 vol. %
cyclomethicone and isoparaffin/alkane, respectively.
18. The antiperspirant product of claim 17, wherein the cyclomethicone comprises cyclopentasiloxane or cyclotetrasiloxane.
19. The antiperspirant product of claim 13, wherein an isoparaffin/alkane compound comprises C13-C16 isoparaffin C12-C14 isoparaffin C13-C15 alkane.
20. A process for making an antiperspirant product, the process comprising the steps of:
providing a carrier having a first volatility rate after about 10 minutes in ambient air at about 50°C and 1 atm and a second volatility rate after about 100 minutes in ambient air at about 50°C and 1 atm, wherein the second volatility rate is less than the first volatility rate;
combining the carrier and an active antiperspirant compound at a first temperature to form a mixture; and
cooling the mixture to a lower second temperature.
PCT/US2010/053007 2009-10-19 2010-10-18 Antiperspirant products and processes for fabricating the same WO2011049851A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP10825458A EP2490664A2 (en) 2009-10-19 2010-10-18 Antiperspirant products and processes for fabricating the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/581,516 2009-10-19
US12/581,516 US20110091402A1 (en) 2009-10-19 2009-10-19 Antiperspirant products and processes for fabricating the same

Publications (2)

Publication Number Publication Date
WO2011049851A2 true WO2011049851A2 (en) 2011-04-28
WO2011049851A3 WO2011049851A3 (en) 2011-08-25

Family

ID=43879451

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/053007 WO2011049851A2 (en) 2009-10-19 2010-10-18 Antiperspirant products and processes for fabricating the same

Country Status (3)

Country Link
US (1) US20110091402A1 (en)
EP (1) EP2490664A2 (en)
WO (1) WO2011049851A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130052242A1 (en) * 2011-08-31 2013-02-28 Haiyan Ge Antiperspirant compositions and products having enhanced wetness protection and methods for making the same
US20130171086A1 (en) * 2011-12-29 2013-07-04 The Dial Corporation Antiperspirant compositions and methods for preparing antiperspirant compositions
US20150147105A1 (en) * 2013-11-22 2015-05-28 The Dial Corporation Solid antiperspirant composition with an enhanced evaporative component
US20150144524A1 (en) * 2013-11-22 2015-05-28 The Dial Corporation Solid antiperspirant composition with an enhanced evaporative component

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935224A (en) * 1988-05-26 1990-06-19 The Mennen Company Aerosol antiperspirant composition, including substantivity fluid, capable of being dispensed at reduced spray rate, and packaged aerosol antiperspirant
US5082652A (en) * 1989-08-22 1992-01-21 Larry Mayfield Aerosol deodorant composition and packaged aerosol deodorant
US5635165A (en) * 1995-09-27 1997-06-03 Helene Curtis, Inc. Antiperspirant deodorant compositions
EP0858317A1 (en) * 1995-10-31 1998-08-19 The Procter & Gamble Company Deodorant cosmetic stick composition
US5919437A (en) * 1996-05-24 1999-07-06 Colgate-Palmolive Company Cosmetic cream composition containing silicone gel material
US5804173A (en) * 1996-09-04 1998-09-08 The Procter & Gamble Company Personal care compositions
US5945085A (en) * 1997-06-19 1999-08-31 Church & Dwight Co., Inc. Aerosol deodorant-antiperspirant product
US5997850C1 (en) * 1997-10-29 2001-11-27 Colgate Palmolive Co Antiperspirant actives and formulations made therefrom
US6682749B1 (en) * 1998-04-03 2004-01-27 Colgate-Palmolive Company Low Residue cosmetic composition
FR2782005B1 (en) * 1998-08-10 2001-07-27 Oreal NON-TRANSFER MAKEUP OR CARE COMPOSITION CONTAINING VOLATILE LINEAR SILICONE
US6350460B1 (en) * 1999-03-10 2002-02-26 Colgate-Palmolive Company Cosmetic stick composition
US7011822B2 (en) * 2000-04-04 2006-03-14 Colgate-Palmolive Company Effective soft solid personal care product
US6352688B1 (en) * 2000-05-17 2002-03-05 The Procter & Gamble Company High efficacy, low residue antiperspirant stick compositions
US6403067B1 (en) * 2000-05-19 2002-06-11 Colgate-Palmolive Company Stable emulsions for cosmetic products
US6403069B1 (en) * 2000-10-20 2002-06-11 Colgate-Palmolive Company High oil clear emulsion with elastomer
US6387357B1 (en) * 2000-10-20 2002-05-14 Colgate-Palmolive Company High oil clear emulsion with diene elastomer
US6964773B1 (en) * 2000-11-22 2005-11-15 L'oreal S.A. Transfer resistant anhydrous cosmetic composition
US6511658B2 (en) * 2000-12-21 2003-01-28 Colgate-Palmolive Company High efficacy antiperspirant stick with concentrated elastomer
US6511657B2 (en) * 2001-04-20 2003-01-28 Colgate-Palmolive Company Two-phase roll-on cosmetic product
US6719966B2 (en) * 2002-04-23 2004-04-13 Andrew Jergens Company Creamy, stable homogeneous antiperspirant/deodorant composition
US20040141934A1 (en) * 2003-01-17 2004-07-22 Colgate-Palmolive Company Two-phase roll-on cosmetic product
JP2004346046A (en) * 2003-05-26 2004-12-09 Shin Etsu Chem Co Ltd Cosmetic
JP2011503192A (en) * 2007-11-13 2011-01-27 プレスパース、エルエルシー Silicon-free hydrocarbons that impart texture and volatility

Also Published As

Publication number Publication date
US20110091402A1 (en) 2011-04-21
WO2011049851A3 (en) 2011-08-25
EP2490664A2 (en) 2012-08-29

Similar Documents

Publication Publication Date Title
US4120948A (en) Two phase antiperspirant compositions
US20110038822A1 (en) Antiperspirant emulsion products and processes for making the same
US20110091402A1 (en) Antiperspirant products and processes for fabricating the same
US20140199252A1 (en) Silicone-free antiperspirant compositions and methods for manufacturing silicone-free antiperspirant compositions
US20120009232A1 (en) Antiperspirant compositions and methods for manufacturing antiperspirant compositions
EP2809294B1 (en) Antiperspirant emulsion compositions and processes for making antiperspirant emulsion compositions
EP2747745B1 (en) Soft solid antiperspirant compositions including stearyl alcohol and cetyl and/or myristyl alcohol
US20120009136A1 (en) Antiperspirant products comprising natural phospholipids and methods for manufacturing the same
EP2797572A1 (en) Antiperspirant compositions and methods for preparing antiperspirant compositions
US20120009137A1 (en) Antiperspirant compositions with whiter color and enhanced skin feel and methods for manufacturing the same
US8481012B2 (en) Antiperspirant emulsion products and processes for making antiperspirant emulsion products
EP2750655B1 (en) Antiperspirant compositions and products having enhanced wetness protection and methods for making the same
US10342749B2 (en) Antiperspirant compositions comprising alums
US9724543B2 (en) Antiperspirant products comprising active antiperspirant compounds surface treated with hydrophobizing agents and methods for manufacturing the same
US20130230475A1 (en) Antiperspirant emulsion products and processes for making the same
US20120135057A1 (en) Antiperspirant compositions and products having a dispersed cooling sensation agent and methods for making the same
EP2908799A1 (en) Soft solid antiperspirant compositions including soy wax and methods of preparing the same
US20140120046A1 (en) Methods for making clear stick antiperspirant compositions and products

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10825458

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2010825458

Country of ref document: EP